Professional Marketing briefs

Share this article:
Baxter Healthcare has selected Purohit Navigation as its agency of record to launch hylenex recombinant (hyaluronidase human injection) for hospital-based rehydration. Hylenex recombinant is the first and only human recombinant hyaluronidase that is used to facilitate subcutaneous rehydration.  
    
Cegedim Dendrite announced the commercial availability of the latest version of its flagship suite, Mobile Intelligence 5.0. According to company officials, it provides robust functionality to improve the effectiveness of commercial teams within a life sciences company such as primary care, specialty care, managed care, key account management, consumer health, key opinion leader management and animal health. The product enables centralization of key customer information across the enterprise.

Boehringer Ingelheim will cut about 800 jobs, 30% of its sales force by November. According to a company spokesperson, the move is in line with the company's overall reorganization strategy.  A little more than 2,200 reps will remain after the downsizing. In April 2009, BI said a safe forecast for business development in 2009 and beyond is difficult.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?